Microbot Medical Strengthens LIBERTY® Robotic System Portfolio with Acquisition of Novel FDA-Cleared Devices
07 oct. 2022 08h36 HE
|
Microbot Medical Inc.
Integration with the LIBERTY® Robotic System & One & Done™ Technology May Enable Future Acceleration of Robotic Adoption; Represents an Additional Growth Opportunity by Accessing the $500...
Microbot Medical Announce Strategic Addition to Scientific Advisory Board Appointment
04 oct. 2022 08h30 HE
|
Microbot Medical Inc.
HINGHAM, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), which continues to be committed to expanding its capabilities, today announced the newest appointment to its...
Microbot Medical Attracts Another Leading Physician and Expands Capabilities of its Scientific Advisory Board with Addition of Dr. Ripal Gandhi
19 sept. 2022 07h00 HE
|
Microbot Medical Inc.
Miami-based Physician Specializes in Minimally Invasive Treatments for Peripheral Vascular Disease, Cancer, and Other Diseases HINGHAM, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Microbot Medical...
Microbot Medical Enhances its Scientific Advisory Board (SAB) with its Newest Member Dr. Vincent Vidal
15 sept. 2022 09h00 HE
|
Microbot Medical Inc.
HINGHAM, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), which continues to build a network of global leaders in the endovascular interventional space for the...
Microbot Medical to Review Recent Progress During H.C. Wainwright’s 24th Annual Global Investment Conference
13 sept. 2022 07h00 HE
|
Microbot Medical Inc.
HINGHAM, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that Harel Gadot, Chairman, President and CEO, will be presenting at the H.C. Wainwright 24th...
Microbot Medical Commenced its First Step in the Anticipated Regulatory Process for its LIBERTY® Robotic System
12 sept. 2022 08h00 HE
|
Microbot Medical Inc.
HINGHAM, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announces the commencement of its GLP Pre-Clinical Trial for the LIBERTY Robotic System at a world-class...
Microbot Medical Strengthen its Scientific Advisory Board with the Recent Addition of Dr. Sebastian Flacke
08 sept. 2022 07h00 HE
|
Microbot Medical Inc.
A global leader in the endovascular space will collaborate with the Company as it goes through the regulatory process and future commercialization HINGHAM, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) --...
Microbot Medical Secures Design Patent Grant in Europe for the LIBERTY® Robotic System
06 sept. 2022 09h00 HE
|
Microbot Medical Inc.
HINGHAM, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Demonstrating another key achievement, Microbot Medical Inc. (Nasdaq: MBOT), continues to execute its objective of expanding its global...
Microbot Medical Confirms GLP Pre-Clinical Trial is on Track to Commence Later this Month
02 sept. 2022 07h00 HE
|
Microbot Medical Inc.
HINGHAM, Mass., Sept. 02, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced, as part of the preparation for its anticipated U.S. Food and Drug Administration (FDA) and CE Mark...
Microbot Medical to Present the Self-Cleaning Shunt at the 16th Asian Australasian Congress of Neurological Surgeons
18 août 2022 07h00 HE
|
Microbot Medical Inc.
HINGHAM, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that it will be presenting the Company’s Self-Cleaning Shunt (SCS) at the 16th Asian Australasian...